These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 26411032)

  • 1. Screening of Microbial Extracts for Anticancer Compounds Using Streptomyces Kinase Inhibitor Assay.
    Shanbhag P; Bhave S; Vartak A; Kulkarni-Almeida A; Mahajan G; Villanueva I; Davies J
    Nat Prod Commun; 2015 Jul; 10(7):1287-91. PubMed ID: 26411032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying protein kinase inhibitors using an assay based on inhibition of aerial hyphae formation in Streptomyces.
    Waters B; Saxena G; Wanggui Y; Kau D; Wrigley S; Stokes R; Davies J
    J Antibiot (Tokyo); 2002 Apr; 55(4):407-16. PubMed ID: 12061549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of potential chemopreventive agents using biochemical markers of carcinogenesis.
    Sharma S; Stutzman JD; Kelloff GJ; Steele VE
    Cancer Res; 1994 Nov; 54(22):5848-55. PubMed ID: 7954413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cancer with small-molecular-weight kinase inhibitors.
    Fabbro D; Cowan-Jacob SW; Möbitz H; Martiny-Baron G
    Methods Mol Biol; 2012; 795():1-34. PubMed ID: 21960212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
    Avramis IA; Laug WE; Sausville EA; Avramis VI
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanidinium-based derivatives: searching for new kinase inhibitors.
    Diez-Cecilia E; Kelly B; Perez C; Zisterer DM; Nevin DK; Lloyd DG; Rozas I
    Eur J Med Chem; 2014 Jun; 81():427-41. PubMed ID: 24858546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening of protein kinase inhibitors].
    Uehara Y; Murakami Y; Fukazawa H
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):491-4. PubMed ID: 15114688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug design and testing: profiling of antiproliferative agents for cancer therapy using a cell-based methyl-[3H]-thymidine incorporation assay.
    Griffiths M; Sundaram H
    Methods Mol Biol; 2011; 731():451-65. PubMed ID: 21516428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and characterization of microbial inhibitors against eukaryotic protein phosphatases (PP1 and PP2A).
    Ong SM; Voo LY; Lai NS; Stark MJ; Ho CC
    J Appl Microbiol; 2007 Mar; 102(3):680-92. PubMed ID: 17309617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioassays for anticancer activities.
    McCauley J; Zivanovic A; Skropeta D
    Methods Mol Biol; 2013; 1055():191-205. PubMed ID: 23963912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening with COMPARE analysis for telomerase inhibitors.
    Naasani I; Yamori T; Tsuruo T
    Methods Mol Biol; 2002; 191():197-207. PubMed ID: 11951607
    [No Abstract]   [Full Text] [Related]  

  • 12. A new screening method for ATP-independent kinase inhibitors identifies repurposed anti-cancer drugs.
    Timaner M; Shaked Y
    EBioMedicine; 2018 Nov; 37():21-22. PubMed ID: 30509398
    [No Abstract]   [Full Text] [Related]  

  • 13. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
    Faivre S; Djelloul S; Raymond E
    Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solphenazines A-F, glycosylated phenazines from Streptomyces sp. strain DL-93.
    Rusman Y; Oppegard LM; Hiasa H; Gelbmann C; Salomon CE
    J Nat Prod; 2013 Jan; 76(1):91-6. PubMed ID: 23317013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-Deoxy-13-hydroxy-8,11-dione-dihydrogranaticin B, an intermediate in granaticin biosynthesis, from Streptomyces sp. CPCC 200532.
    Jiang B; Li S; Zhao W; Li T; Zuo L; Nan Y; Wu L; Liu H; Yu L; Shan G; Zuo L
    J Nat Prod; 2014 Sep; 77(9):2130-3. PubMed ID: 25153802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4.
    Kubo A; Nakagawa K; Varma RK; Conrad NK; Cheng JQ; Lee WC; Testa JR; Johnson BE; Kaye FJ; Kelley MJ
    Clin Cancer Res; 1999 Dec; 5(12):4279-86. PubMed ID: 10632371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enzyme-linked immunosorbent assay to screen for inhibitors of the oncogenic anaplastic lymphoma kinase.
    Gunby RH; Tartari CJ; Porchia F; Donella-Deana A; Scapozza L; Gambacorti-Passerini C
    Haematologica; 2005 Jul; 90(7):988-90. PubMed ID: 15996942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible role of the effect of methionine on the activity of aspartokinase in sporulation of a Streptomyces fradiae mutant.
    Vargha G
    Acta Biol Hung; 1997; 48(3):281-8. PubMed ID: 9406608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of some 2-(3,5-dimethyl-1H-pyrazol-1-yl)-1-arylethanones: antibacterial, DNA photocleavage, and anticancer activities.
    Kumar V; Kaur K; Karelia DN; Beniwal V; Gupta GK; Sharma AK; Gupta AK
    Eur J Med Chem; 2014 Jun; 81():267-76. PubMed ID: 24849271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.
    Remsing Rix LL; Rix U; Colinge J; Hantschel O; Bennett KL; Stranzl T; Müller A; Baumgartner C; Valent P; Augustin M; Till JH; Superti-Furga G
    Leukemia; 2009 Mar; 23(3):477-85. PubMed ID: 19039322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.